IL15 and primary cutaneous T-cell non-Hodgkin lymphoma: This model mirrors the high levels of IL-15 found in CTCL patients and allows for the observation of clinical symptoms and disease progression in vivo, aiding in the understanding of the role of IL-15 in the pathogenesis of CTCL (Mishra et al., 2016; Sindaco et al., 2023).